A new NTI | bio report describes the status of benchtop DNA synthesis devices, explains the risks for biosecurity, and recommends action and oversight by governments, industry, and the scientific community.
Practical solutions for organizations involved in life science research to manage risks and prevent accidents, misuse, and other adverse outcomes stemming from their work.
In a new opinion piece for The Economist, Jaime Yassif makes the case for urgent action to create stronger guardrails for bioscience and biotechnology.
A new NTI | bio report released today on the sidelines of the Biological Weapons Convention Meeting of States Parties, “Strengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats,” outlines actionable recommendations for the international community to bolster prevention and response capabilities for high-consequence biological events.
Understanding biological weapons, as well as biosafety, biosecurity, and BW nonproliferation, is the focus of this tutorial.
The first comprehensive assessment of global health security capabilities in 195 countries.
The first comprehensive assessment and benchmarking of health security and related capabilities across the 195 countries that make up the States Parties to the International Health Regulations.
The working group on Insurance Incentives for Reducing Biological Risks, informed by a paper drafted ahead of the October 2018 Initiative launch.
This page describes the working group on Standards for Funders, Grantees, and Publishers to Identify and Mitigate Biological Risks
